Skip to main navigation Skip to search Skip to main content

Intravenous trimethylamine N-oxide infusion does not modify circulating markers of liver health, glucose tolerance, and milk production in early-lactation cows

  • William A. Myers
  • , Feiran Wang
  • , Crystal Chang
  • , Amanda N. Davis
  • , J. Eduardo Rico
  • , Brianna N. Tate
  • , Tanya L. France
  • , Linfeng F. Wang
  • , Joseph W. McFadden
  • Cornell University
  • China Agricultural University
  • Henan Agricultural University

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

In rodents and humans, the gut bacteria-derived metabolite trimethylamine N-oxide (TMAO) has been implicated in the progression of cardiovascular disease, chronic kidney disease, fatty liver, and insulin resistance; however, the effects of TMAO on dairy cattle health and milk production have not been defined. We aimed to determine whether intravenous TMAO infusion modifies measures of liver health, glucose tolerance, and milk production in early-lactation cows. Eight early-lactation Holstein cows (30.4 ± 6.41 d in milk; 2.88 ± 0.83 lactations) were enrolled in a study with a replicated 4 × 4 Latin square design. Cows were intravenously infused TMAO at 0 (control), 20, 40, or 60 g/d for 6 d. Washout periods lasted 9 d. Intravenous glucose tolerance tests (GTT) occurred on d 5. Blood was collected daily. Milk was collected on d −1, 0, 5, and 6. Urine was collected on d −1 and 6. Circulating metabolites, milk components, and TMAO concentrations in milk, urine, and plasma were quantified. Data were analyzed using a mixed model that included the fixed effects of treatment. Concentrations of TMAO in plasma, milk, and urine increased linearly with increasing dose. Dry matter intake and milk production were not modified by treatment. Daily plasma triacylglycerol, fatty acid (FA), and glucose concentrations were not modified. Serum albumin, total protein, globulin, total bilirubin, direct bilirubin, aspartate aminotransferase, γ-glutamyl transferase, and glutamate dehydrogenase concentrations were also not modified by treatment. Serum GTT glucose, FA, and insulin concentrations were not modified by treatment. Plasma total, reduced, and oxidized glutathione concentrations were also not modified by treatment. We conclude that a 6-d intravenous infusion of TMAO does not influence measures of liver health, glucose tolerance, or milk production in early-lactation dairy cows.

Original languageEnglish
Pages (from-to)9948-9955
Number of pages8
JournalJournal of Dairy Science
Volume104
Issue number9
DOIs
StatePublished - Sep 2021

Keywords

  • dairy cow
  • metabolic health
  • trimethylamine N-oxide

Fingerprint

Dive into the research topics of 'Intravenous trimethylamine N-oxide infusion does not modify circulating markers of liver health, glucose tolerance, and milk production in early-lactation cows'. Together they form a unique fingerprint.

Cite this